Nurbanu Yaşar

Nurbanu Yaşar

Auto-generated profile, based on publicly available information

Nurbanu Yaşar

Mersin Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Mersin

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2023 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
NYNurbanu Yaşar
Nurbanu Yaşar
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
MÜMahmut Ülger
Mahmut Ülger
AAAhmet Arslantürk
Ahmet Arslantürk
GAGonul Aslan
Gonul Aslan
FKFatih Köksal
Fatih Köksal
Ethambutol (EMB) is one of the first-line drugs used in the standard combination therapy for tuberculo- sis (TB) caused by Mycobacterium tuberculosis complex (MTC), and resistance to drugs that play a key role in treatment is increasing worldwide. Mutations in the embCAB operon that have been confirmed to be associated with resistance are responsible for EMB resistance. In this study, it was aimed to determine the frequency and patterns of mutations in embA, embB and embC gene regions in clinical MTC isolates found to be phenotypically resistant and susceptible to EMB. A total of 64 MTC isolates, 44 of resistant to EMB and 20 of susceptible to EMB, isoniazid, rifampicin, and streptomycin by conventional phenotypic drug susceptibility test, were included in the study. Following the DNA isolation, embA, embB and embC gene regions associated with EMB resistance were amplified with specific primer sequences. The PCR products were cycle sequenced using the Bigdye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems, USA) and electrophoretically separated on the ABI PRISM 3130XL Genetic Analyzer (Applied Biosystems, USA). Mutated gene regions were identified by aligning sequence analysis data in multiple sequence analysis programs. In the study, genomic mutations in the embCAB operon were detected in 68.2% (30/44) of the EMB resistant isolates. Mutations in the embB gene region were detected in 66% (29/44) of the resistant isolates, 76% (22/29) of these mutations were at codon 306 and the most common mutation patterns in this codon were determined as ATG-*GTG (M306V; 58.6%; 17/29), ATG-*ATA, ATC or ATT (M306I; 17.2%; 5/29). Other mutations in the embB gene region were determined as Y334H (3.4%; 1/29), D354A (6.9%; 2/29), E378A (3.4%; 1/29), G406C (3.4%; 1/29), M423I (3.4%; 1/29) and E521A (3.4%; 1/29). Of the 44 EMB-resistant isolates, mutations were detected in one (2.3%) of the isolate in the embA gene region (L330L) and in two (4.5%) of the isolates in the embC gene region (T270I in one isolate and T270I and E305E in the other isolate). Of the phenotypically EMB susceptible isolates, mutation was detected in only one (5%) of the isolates in the embA gene region (E180G). In our study, it was determined that muta- tions frequently occur in codon 306 of the embB gene in EMB-resistant MTC isolates and this mutation has a potential role in the development of EMB resistance. However, it was concluded that the absence of mutations does not exclude phenotypic EMB resistance. Our results will shed light on the molecular of embCAB mutations that cause EMB resistance in our

26 July 2025 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
NYNurbanu Yaşar
Nurbanu Yaşar
YBYüksel Balci
Yüksel Balci
GAGözde Arslan
Gözde Arslan
EBEsma Baş
Esma Baş
NDNuran Delialioğlu
Nuran Delialioğlu
EÖEylem Sercan Özgür
Eylem Sercan Özgür
Lophomonas blattarum, genellikle alt solunum yollarını enfekte eden ve bronkopulmoner enfeksiyonlara neden olan bir protozoondur. Klinik bulguları özgül olmamakla birlikte; öksürük, balgam, ateş, göğüs rahatsızlığı ve solunum sıkıntısı gibi semptomları içerebilir. Lophomonas enfeksiyonunun tanısı, solunum sekresyonlarından elde edilen örneklerin ışık mikroskobuyla incelenerek parazitin morfolojik olarak tespit edilmesine dayanmaktadır. Parazitin silyalı bronşiyal epitel hücrelerinden ayırt edilmesi zordur ve bu ayrım, doğru tanı için kritik öneme sahiptir. Bu olgu raporunda, bağışıklık sistemi sağlam yetişkin bir erkekte L.blattarum saptanan bir vaka sunulmuştur. Kırk altı yaşındaki erkek hasta, hemoptizi, efor dispnesi, halsizlik, gece terlemesi ve balgamlı öksürük şikayetiyle hastaneye başvurmuştur. Toraks bilgisayarlı tomografide sağ üst lobda 2 cm apse/kist, komşuluğunda konsolidasyon/atelektazi ve buzlu cam dansiteleri gözlemlenmiştir. Pnömoni ön tanısıyla ampirik tedavi başlanmıştır. Hemoptizi nedeniyle fiberoptik bronkoskopi yapılmıştır. Hastadan asidorezistan basil incelemesi, kültür ve doğrudan mikroskobik inceleme için balgam ve bronkoalveolar lavaj (BAL) sıvısı örnekleri alınmıştır. BAL örneğinin doğrudan mikroskobik incelemesi ve Giemsa boyasıyla L.blattarum'a morfolojik olarak benzer trofozoitler gözlenmiştir. Tanının doğrulanması amacıyla yapılan polimeraz zincir reaksiyon analizinde hedef parazite özgü güvenilir sonuç elde edilememiştir. Bu nedenle, mikroskobik bulgularla uyumlu olarak olası Lophomonas enfeksiyonu düşünülmüş ve diğer nonspesifik antibiyotik tedavileri kesilerek metronidazol başlanmıştır. Tedavi sonrası, klinik ve radyolojik bulgularında dramatik bir iyileşme gözlenen hasta, sağlığına kavuşarak taburcu edilmiştir. Bu vaka, bağışıklık sistemi sağlam bireylerde de Lophomonas enfeksiyonunun görülebileceğini ve bronkopulmoner enfeksiyonlarla karışabilen bir klinik tabloya yol açabileceğini göstermektedir. Tanıda mikroskobik değerlendirmenin önemini vurgulamakla birlikte, moleküler yöntemlerin standart hale getirilmesinin gerekliliğini de ortaya koymaktadır. Klinik pratikte ampirik antibiyotik tedavisine cevap vermeyen olgularda lophomoniasis olasılığı göz ardı edilmemeli ve her şüpheli vaka dikkatle değerlendirilmelidir.

20 August 2020 in Meandros Medical and Dental Journal
Verified
Journal Article
Closed access
BKBertan Kesim
Bertan Kesim
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
HTHüseyin Sinan Topçuoğlu
Hüseyin Sinan Topçuoğlu
GAGonul Aslan
Gonul Aslan
NKNurbanu Kurnaz
Nurbanu Kurnaz
BSBurak Sağsen
Burak Sağsen

21 January 2022 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
LELeyla Ersoy
Leyla Ersoy
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
HGHarun Gülbudak
Harun Gülbudak
NYNurbanu Yaşar
Nurbanu Yaşar
GYGulcin Yapici
Gulcin Yapici
GAGonul Aslan
Gonul Aslan
The impact of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome 2 (SARS-CoV-2) still continues. The duration of the immune response in individuals recovering from COVID-19 and its protection against future SARS-CoV-2 infection are not fully understood. This study aimed to longitudinally evaluate anti-SARS-CoV-2 seroconversion status in healthcare workers with positive SARS-CoV-2 Real-time reverse transcription polymerase chain reaction (rRT-PCR), test in Mersin University Hospital. A total of 68 healthcare workers with positive SARS-CoV-2 rRT-PCR test between 19 April and 27 November 2020 were included in the study. Blood samples were collected from healthcare workers for SARS-CoV-2 antibody testing in the 1st, 3rd and 5th months following PCR positivity. Healthcare workers were classified as symptomatic, asymptomatic and reinfected according to their clinical findings, and rRT-PCR cycle thresholds (Ct) were recorded. Elecsys Anti-SARS-CoV-2 (Roche Diagnostics, Germany) kit was used for antibody testing. Of the 68 healthcare workers; 46 were classified as symptomatic, 15 as asymptomatic, and seven as reinfected. Twenty-seven (39.7%) of the healthcare workers were male and 41 (60.3%) were female, and the mean age was 36.4 ± 9.04. Seroconversion was detected in 45 (66.2%) of 68 healthcare workers in the study, and only one person had sero-negative result at the end of the 5th month. While seroconversion was detected in 78.3% (n= 36/46) of symptomatic healthcare workers, it was observed in 26.7% (n= 4/15) of the asymptomatic healthcare workers. Seroconversion was detected in only one of the seven reinfected healthcare workers after primary infection. After reinfection, seroconversion was observed in five of seven reinfected healthcare workers. Antibody response was not detected in two of them after both infections. According to the rRT-PCR Ct values; the median of Ct value was found significantly lower in healthcare workers with seroconversion (23.26, IQR= 18.45-27.30), than the ones without seroconversion (36.20, IQR= 33.09-37.56) (p< 0.001). In those who had reinfection, the mean Ct value (31.77 ± 6.62) detected during the primary infection period was statistically higher than the Ct value (22.44 ± 5.54) detected during reinfection (p= 0.008). The most frequently recorded symptoms in healthcare workers were myalgia (57.3%), fatigue (51.5%), headache (51.5%) followed by sore throat (36.7%), fever (33.8%), cough (27.9%), diarrhea (23.5%) and dyspnea (16.2%). In addition, fever (52%) and fatigue (80.6%) were found to be significantly higher in seroconversion-positive healthcare workers than in those without seroconversion (p= 0.028; p= 0.005, respectively). As a result, a higher rate of antibody response was detected in healthcare workers who had symptomatic infection than those who were asymptomatic. It has been observed that patients with asymptomatic primary infection and without antibody response were more susceptible to reinfection. In addition, it was observed that the probability of immune response increased when the viral load increased (Ct value decreased) in symptomatic infections. Although these findings provide important information about the short-term seroconversion status of healthcare personnel; longer-term and larger-scale studies are needed to evaluate the long-term effectiveness of seroconversion and to better understand the effectiveness of the immune response developed after SARS-CoV-2 vaccine administrations.

12 March 2026 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
BABurak AK
Burak AK
NYNurbanu Yaşar
Nurbanu Yaşar
DGDamla Eda Yapıcı Gülbey
Damla Eda Yapıcı Gülbey
SÜSeda Tezcan Ülger
Seda Tezcan Ülger
Aims: This study aimed to evaluate the antifungal effects of methylene blue (MB)-mediated antimicrobial photodynamic therapy (aPDT), alone and in combination with simultaneous 808 nm diode laser irradiation on Candida albicans (C. albicans) colonies. Methods: This pilot study was designed as an exploratory in vitro investigation based on qualitative assessment without quantitative or statistical analysis. C. albicans (ATCC 10231) suspensions were homogeneously spread onto Sabouraud Dextrose Agar plates. MB was applied at concentrations ranging from 0.01% to 1%. aPDT was performed using a 630 nm LED for durations of 10 s, 30 s, 1 min, and 2 min. In a separate experimental setup, the simultaneous application of aPDT and an 808 nm diode laser was evaluated. The inhibitory effects on C. albicans growth were visually assessed and compared with control groups.Results: Qualitative visual assessment showed that MB alone demonstrated concentration-dependent antifungal activity, with complete inhibition observed in the 1%. aPDT with MB ≥0.1% eliminated colony formation after 1–2 minutes of irradiation. In the 0.03% and 0.02% groups, aPDT alone did not produce a clear inhibition zone, although growth density decreased after 2 minutes. In the combined treatment (aPDT+808 nm laser), efficacy was markedly enhanced. Specifically, in the 0.03% group, where aPDT alone was limited, the addition of the laser resulted in clear inhibition zones.Conclusion: The simultaneous application of aPDT and 808 nm laser resulted in enhanced inhibition of C. albicans. The addition of the diode laser improved antifungal efficacy, enabling effective inhibition at lower MB concentrations (0.03%), where aPDT alone was insufficient.

30 December 2022 in ANKEM DERGİSİ
Verified
Journal Article
Open access
PDF file
MÜMahmut Ülger
Mahmut Ülger
NYNurbanu Yaşar
Nurbanu Yaşar
HKHamide Kaya
Hamide Kaya
EKEyyüp Kaya
Eyyüp Kaya
OSOsman Sezer
Osman Sezer
GAGonul Aslan
Gonul Aslan
Tüberküloz (TB) dünya çapında en yaygın ölüm nedenlerinden biridir. Çok ilaca dirençli tüberküloz (ÇİD-TB) olguları düşük tedavi başarısı, kötü prognoz ve yüksek tedavi maliyetleri ile önemli bir sorundur. Çalışmamızda birinci seçenek anti-TB ilaçlara duyarlı Mycobacterium tuberculosis kompleks (MTC) izolatlarının ve ÇİD-TB izolatlarının amikasin (AK), moksifloksasin (MOKS) ve kanamisin (KAN) duyarlılıklarını resazurin mikrotitre plak yöntemi ile araştırılması amaçlanmıştır. Mikobakteriyoloji laboratuvarı kültür koleksiyonundan birinci seçenek ilaçlara duyarlı 19 izolat ile izoniazid ve rifampisine dirençli (ÇİD-TB) 12 izolat olmak üzere toplam 31 adet MTC izolatı çalışmaya dahil edilmiştir. Duyarlı izolatlarda her üç ilaca da direnç saptanmamıştır. ÇİD-TB izolatlarından üçü (3/12) AK’a, ikisi (2/12) MOKS’a ve dördü (4/12) KAN’a dirençli bulunmuştur. ÇİD-TB izolatlarından bir tanesinin her üç ilaca da dirençli olduğu saptanmıştır. ÇİD-TB izolatları arasında yaygın ilaç direnci (YİD-TB) %8 (1/12) olarak tespit edilmiştir. Çok ilaca direnç gelişiminden sonra YİD-TB görülmesi TB tedavi başarısında önemli bir sorundur ve tedavide etkin yol izleyebilmek için direnç profillerini belirlemek gereklidir. Çalışmamızda ÇİD-TB izolatlarında saptanan AK, MOKS ve KAN direncinin hem anti-TB tedavisinin daha sıkı takip edilmesine hem de yapılacak olan çalışmalara katkı sağlayacağı kanaatindeyiz.